Skip to main content
logo
Xenetic Biosciences, Inc. (XBIO)
NASDAQ: XBIO · Real-Time Price · USD
2.660
0.00 (0.00%)
Aug 4, 2026, 7:06 AM EDT - Market open

Xenetic Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-2.23-2.68-3.96-4.13-6.55-5.65
Depreciation & Amortization
----0.030.04
Stock-Based Compensation
0.060.060.170.280.510.41
Other Adjustments
----1.79-
Changes in Accounts Payable
-0.010.070.08-0.26-0.350.46
Changes in Other Operating Activities
0.070.260.890-0.080
Operating Cash Flow
-1.82-2.29-2.82-4.11-4.65-4.74
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Purchases of Intangible Assets
-----0.5-
Investing Cash Flow
-----0.5-

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
-4---11.45
Net Common Stock Issued (Repurchased)
-4---11.45
Financing Cash Flow
-4---11.45

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
2.181.72-2.82-4.11-5.156.72

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-1.82-2.29-2.82-4.11-4.65-4.74
Free Cash Flow Growth
------
FCF Margin
-57.09%-76.83%-112.69%-161.98%-272.23%-408.21%
Free Cash Flow Per Share
-0.96-1.34-1.83-2.69-3.27-4.61
Levered Free Cash Flow
-2.18-2.35-2.99-4.4-6.95-5.15
Unlevered Free Cash Flow
-2.34-2.51-3.23-4.78-7.12-5.25
SEC Filings: 10-K · 10-Q